Ovid Therapeutics Inc (NQ: OVID )

3.700 USD -0.080 (-2.12%)

Official Closing Price Updated: 6:16 PM EDT, Apr 19, 2021 Add to My Watchlist

Price and Volume

Volume	952,900
Open	3.660
Bid (Size)	3.500 (250)
Ask (Size)	3.700 (100)
Prev. Close	3.780
Today's Range	3.600 - 3.842
52wk Range	2.250 - 9.400
Shares Outstanding	65,753,570
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

OVID Provides Update on OV101 Program and the Prioritization of its Resources

Today 8:00 EDT

Ovid Therapeutics Announces Closing of Agreement with Takeda for Global Development and Commercialization of Soticlestat

March 30, 2021

Performance

YTD	+52.26%	+52.26%
1 Month	-13.55%	-13.55%
3 Month	+48.00%	+48.00%
6 Month	-32.73%	-32.73%
1 Year	+6.94%	+6.94%

More News

Ovid Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results, Provides Corporate Update for 2021

March 15, 2021

4 Biotech Penny Stocks To Watch That Are Heating Up This Month

April 18, 2021

Ovid Therapeutics Stops Gaboxadol Development Citing Limited Efficacy In Rare Neurological Conditions

Today 9:16 EDT

First Week of OVID June 18th Options Trading

April 16, 2021

Penny Stocks To Buy According To These Top Analysts Right Now

February 08, 2021

Takeda Secures Global Rights from Ovid Therapeutics to Develop and Commercialize Soticlestat for the Treatment of Children and Adults with Dravet Syndrome and Lennox-Gastaut Syndrome

March 03, 2021

8 Biotech Penny Stocks for Investors to Watch

March 10, 2021

Noteworthy Wednesday Option Activity: LYFT, OVID, HRI

March 03, 2021

12 Health Care Stocks Moving In Wednesday's Intraday Session

March 03, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.